PLASMA FIBRINOGEN LEVEL INDEPENDENTLY PREDICTS THE PROGNOSIS OF PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA

被引：0
|
作者：
Obata, Jun
Tanaka, Nobuyuki
Mizuno, Ryuichi
Morita, Shinya
Shinoda, Kazunobu
Kosaka, Takeo
Shinojima, Toshiaki
Kikuchi, Eiji
Asanuma, Hiroshi
Miyajima, Akira
Oya, Mototsugu
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP35-20
引用
收藏
页码：E427 / E427
页数：1
相关论文
共 50 条
  • [1] Renal parenchymal infiltration is the primary determinant of prognosis of patients with non-metastatic clear cell renal cell carcinoma
    Tanaka, H.
    Fukawa, Y.
    Yamamoto, K.
    Fukuda, S.
    Uehara, S.
    Yoshida, S.
    Yokoyama, M.
    Matsuoka, Y.
    Campbell, S. C.
    Fujii, Y.
    EUROPEAN UROLOGY, 2022, 81 : S1476 - S1477
  • [2] FINANCIAL TOXICITY IN NON-METASTATIC RENAL CELL CARCINOMA PATIENTS
    Staehler, Michael
    Ebrahimi, Hedyeh
    Rodler, Severin
    Vaishampayan, Ulka
    Msouel, Pavlos
    Ball, Mark
    Derweesh, Ithaar
    Battle, Dena
    JOURNAL OF UROLOGY, 2023, 209 : E232 - E232
  • [3] Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: A multicenter study
    Lee, Won Ki
    Byun, Seok-Soo
    Kim, Hyeon Hoe
    Rha, Koon Ho
    Hwang, Tae-Kon
    Sung, Gyung Tak
    Lee, Wan
    Lim, Jae Sung
    Jeong, Young Beom
    Kwon, Tae Gyun
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 (11) : 898 - 904
  • [4] Beta-1,4-galactosyltransferase II predicts poor prognosis of patients with non-metastatic clear-cell renal cell carcinoma
    Zhang, Haijian
    Liu, Yidong
    Xie, Huyang
    Fu, Qiang
    Liu, Zheng
    Zhu, Yu
    Xu, Le
    Zhang, Weijuan
    Yang, Yuanfeng
    Xu, Jiejie
    TUMOR BIOLOGY, 2017, 39 (02) : 1 - 11
  • [5] FINANCIAL TOXICITY IN NON-METASTATIC VERSUS METASTATIC RENAL CELL CARCINOMA PATIENTS
    Staehler, Michael D.
    Vaishampayan, Ulka
    Pal, Sumanta K.
    Msaouel, Pavlos
    Derweesh, Ithaar
    Penson, David F.
    Battle, Dena J.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1220 - E1220
  • [6] IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma
    Bai, Qi
    Liu, Li
    Xia, Yu
    Wang, Jiajun
    Xi, Wei
    Qu, Yang
    Xiong, Ying
    Long, Qilai
    Xu, Jiejie
    Guo, Jianming
    ONCOTARGET, 2017, 8 (27) : 44186 - 44194
  • [7] Preoperative systemic immune-inflammation index predicts prognosis of patients with non-metastatic renal cell carcinoma: a propensity score-matched analysis
    Hu, Xu
    Shao, Yan-Xiang
    Yang, Zhi-Qiang
    Dou, Wei-Chao
    Xiong, San-Chao
    Li, Xiang
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [8] Preoperative systemic immune-inflammation index predicts prognosis of patients with non-metastatic renal cell carcinoma: a propensity score-matched analysis
    Xu Hu
    Yan-Xiang Shao
    Zhi-Qiang Yang
    Wei-Chao Dou
    San-Chao Xiong
    Xiang Li
    Cancer Cell International, 20
  • [9] Multidisciplinary team referral at diagnosis for patients with non-metastatic renal cell carcinoma
    Martini, Alberto
    Fallara, Giuseppe
    Pellegrino, Antony A.
    Nocera, Luigi
    Larcher, Alessandro
    Raggi, Daniele
    Campi, Riccardo
    Ploussard, Guillaume
    Malavaud, Bernard
    Montorsi, Francesco
    Pal, Sumanta K.
    Spiess, Philippe E.
    Choueiri, Toni K.
    Necchi, Andrea
    Capitanio, Umberto
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (08) : 384.e9 - 384.e14
  • [10] Elevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma
    Liu, Weisi
    Liu, Yidong
    Fu, Qiang
    Zhou, Lin
    Chang, Yuan
    Xu, Le
    Zhang, Weijuan
    Xu, Jiejie
    ONCOTARGET, 2016, 7 (12) : 13976 - 13983
12345